Vann Jones SA, O’Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673–83.

Article  PubMed  CAS  Google Scholar 

Hogan DB, Fiest KM, Roberts JI, et al. The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review. Can J Neurol Sci J Can Sci Neurol. 2016;43(Suppl 1):S83–95.

Article  Google Scholar 

Lee CY, Cheng SJ, Lin HC, Liao YL, Chen PH. Quality of Life in Patients with Dementia with Lewy Bodies. Behav Neurol. 2018;2018:8320901.

Article  PubMed  PubMed Central  Google Scholar 

Rigby T, Johnson DK, Taylor A, Galvin JE. Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer’s Disease, and Parkinson’s Disease Dementia. J Alzheimers Dis JAD. 2021;80(1):421–32.

Article  PubMed  CAS  Google Scholar 

McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.

Article  PubMed  PubMed Central  Google Scholar 

Thomas AJ, Donaghy P, Roberts G, et al. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med. 2019;49:396–402.

Article  PubMed  Google Scholar 

Bousiges O, Blanc F. Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease. Int J Mol Sci. 2022;23(12):6371.

Article  PubMed  PubMed Central  CAS  Google Scholar 

van Steenoven I, Aarsland D, Weintraub D, et al. Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort. J Alzheimers Dis JAD. 2016;54(1):287–95.

Article  PubMed  Google Scholar 

Lemstra AW, de Beer MH, Teunissen CE, et al. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2017;88(2):113–8.

Article  PubMed  CAS  Google Scholar 

Bousiges O, Blanc F. Diagnostic value of cerebro-spinal fluid biomarkers in dementia with lewy bodies. Clin Chim Acta Int J Clin Chem. 2019;490:222–8.

Article  CAS  Google Scholar 

Kasuga K, Tokutake T, Ishikawa A, et al. Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2010;81(6):608–10.

Article  PubMed  Google Scholar 

van Steenoven I, Majbour NK, Vaikath NN, et al. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. Mov Disord Off J Mov Disord Soc. 2018;33(11):1724–33.

Article  Google Scholar 

Eusebi P, Giannandrea D, Biscetti L, et al. Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson’s disease: A systematic review and meta-analysis. Mov Disord Off J Mov Disord Soc. 2017;32(10):1389–400.

Article  CAS  Google Scholar 

Bongianni M, Ladogana A, Capaldi S, et al. α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann Clin Transl Neurol. 2019;6(10):2120–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yoo D, Bang JI, Ahn C, et al. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2022;104:99–109.

Article  PubMed  CAS  Google Scholar 

Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology. 1995;45(1):182–4.

Article  PubMed  CAS  Google Scholar 

Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008;7(11):1044–55.

Article  PubMed  Google Scholar 

Berg D. Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: yes. J Neural Transm (Vienna). 2011;118(4):613–9.

Article  PubMed  Google Scholar 

Iranzo A, Stockner H, Serradell M, et al. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord Off J Mov Disord Soc. 2014;29(14):1774–80.

Article  Google Scholar 

Vilas D, Iranzo A, Pont-Sunyer C, et al. Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression. J Neurol. 2015;262(7):1665–72.

Article  PubMed  CAS  Google Scholar 

Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson’s disease with dementia. J Neurol. 2006;253(4):448–54.

Article  PubMed  Google Scholar 

Favaretto S, Walter U, Baracchini C, et al. Accuracy of transcranial brain parenchyma sonography in the diagnosis of dementia with Lewy bodies. Eur J Neurol. 2016;23(8):1322–8.

Article  PubMed  CAS  Google Scholar 

Monaco D, Berg D, Thomas A, et al. The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2018;39(11):1887–94.

Google Scholar 

Miyamoto M, Miyamoto T. Relationship of substantia nigra hyperechogenicity to risk of Lewy body disease in idiopathic REM sleep behavior disorder patients: a longitudinal study. Sleep Med. 2020;68:31–4.

Article  PubMed  Google Scholar 

McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743–55.

Article  PubMed  PubMed Central  Google Scholar 

Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.

Article  PubMed  CAS  Google Scholar 

McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement J Alzheimers Assoc. 2011;7(3):263–9.

Article  Google Scholar 

Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2015;30(12):1591–601.

Article  Google Scholar 

Lobo A, Saz P, Marcos G, et al. Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med Clin (Barc). 1999;112(20):767–74.

PubMed  CAS  Google Scholar 

Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

Article  PubMed  Google Scholar 

Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc. 2008;23(15):2129–70.

Article  Google Scholar 

Walter U, Školoudík D. Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med. 2014;35(4):322–31.

Article  PubMed  CAS  Google Scholar 

Vergouw LJM, Marler LP, van de Berg WDJ, et al. Dementia With Lewy Bodies: A Clinicopathologic Series of False-positive Cases. Alzheimer Dis Assoc Disord. 2020;34(2):178–82.

Article  PubMed  Google Scholar 

Burgio MI, Veronese N, Sarà D, et al. Markers for the detection of Lewy body disease versus Alzheimer’s disease in mild cognitive impairment: a systematic review and meta-analysis. Aging Clin Exp Res. 2024;36(1):60.

Article  PubMed  PubMed Central  Google Scholar 

Mc Keith IG, Dickson DW, Lowe JM, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–72.